MedPath

Progestrone and Doppler Indices

Phase 2
Completed
Conditions
Preterm Labor
Interventions
Diagnostic Test: A complete Doppler flow assessment of the maternal and fetal circulation
Registration Number
NCT03292939
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

The aim of our study is to assess the effect of vaginal progestrone on fetal and maternal doppler indices

Detailed Description

A complete Doppler flow assessment of the maternal and fetal circulation was conducted by an independent investigator blinded to the treatment, before and 48 hours after the first administration of 400mg of vaginal progesterone, Voluson E8 (GE Healthcare, Zipf, Austria) ultrasound machine,equipped with a 3.5- MHz curvilinear abdominal transducer with color imaging capabilities, was used in all cases.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Gestational age: 18-33 weeks
  • Willing and able to give informed consent
  • History of preterm labor (<34 weeks)
  • At risk for preterm labor ( increased amniotic fluid volume)
  • Short cervical length (<25mm) as incidental finding
  • Presenting with actual cervical changes ( dilatation and\or effacement) in current pregnancy
Exclusion Criteria
  • PPROM
  • Contraindication to progesterone use
  • Diabetic patients, have glucose intolerance
  • Multiple pregnancies

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
vaginal progestrone groupA complete Doppler flow assessment of the maternal and fetal circulationcohort of patients who received 400mg vaginal progestrone .
Primary Outcome Measures
NameTimeMethod
change of ultrasound doppler indices.before and 48 hours after progestrone admistration

A complete Doppler flow assessment of the maternaland fetal circulation was conducted by an independent investigator blinded to the treatment, before and 48 hours after the first administration of progesterone, Voluson E8 (GE Healthcare, Zipf, Austria) ultrasoundmachine,equippedwitha3.5-MHzcurvilinearabdominaltransducer with color imaging capabilities, was used in all cases.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasr El Ainiy Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath